The Daily Hair Care Shampoo (200 ml) provides essential nourishment to the scalp and hair
While initial changes happen early on, the majority of weight loss occurs in the subsequent weeks
For long-term handling protocols, see our peptide storage guide
Homeostatic model assessment (HOMA2)-IR index (computed with insulin decreased over time from baseline with RETA 12 mg reaching reductions of 39% in T2D at 36 weeks and 52% in OB at 48 weeks, indicative of reductions in insulin resistance in both populations
Learn how the HPG axis, testosterone, estrogen, and peptides impact sexual health and
Retatrutide for Metabolic Research Retatrutide for Metabolic Dysfunction-Associated Research Retatrutide is currently being investigated for research involving: Obesity Metabolic dysfunction-associated steatotic liver disease Glycemic control Endocrine signaling Weight management Multiple metabolic pathways Triple-Hormone-Receptor Agonist Retatrutide for Obesity Research involving receptor agonist retatrutide for metabolic dysfunction-associated conditions has gained significant interest because the peptide influences: GLP-1 receptor pathways GIP receptor signaling Glucagon receptor activity Energy expenditure Appetite regulation Several phase 2 trial studies involving obesity and glycemic control demonstrated promising metabolic outcomes